AIMS: Stem cell transplantation holds promise as a therapeutic approach for the repair of damaged myocardial tissue. One challenge of this approach is efficient delivery and long-term retention of the stem cells. Although several synthetic and natural biomaterials have been developed for this purpose, the ideal formulation has yet to be identified. MATERIALS & METHODS: Here we investigate the utility of a nondenatured, noncrosslinked, commercially available natural biomaterial (TissueMend(®) [TEI Biosciences, Boston, MA, USA]) for delivery of human mesenchymal stem cells (MSCs) to the murine heart. RESULTS: We found that MSCs attached, proliferated and migrated within and out of the TissueMend matrix in vitro. Human MSCs delivered to damaged murine myocardium via the matrix (2.3 × 10(4) ± 0.8 × 10(4) CD73(+) cells/matrix) were maintained in vivo for 3 weeks and underwent at least three population doublings during that period (21.9 × 10(4) ± 14.4 × 10(4) CD73(+) cells/matrix). In addition, collagen within the TissueMend matrix could be remodeled by MSCs in vivo, resulting in a significant decrease in the coefficient of alignment of fibers (0.12 ± 0.12) compared with the matrix alone (0.28 ± 0.07), and the MSCs were capable of migrating out of the matrix and into the host tissue. CONCLUSION: Thus, TissueMend matrix offers a commercially available, biocompatible and malleable vehicle for the delivery and retention of stem cells to the heart.
AIMS: Stem cell transplantation holds promise as a therapeutic approach for the repair of damaged myocardial tissue. One challenge of this approach is efficient delivery and long-term retention of the stem cells. Although several synthetic and natural biomaterials have been developed for this purpose, the ideal formulation has yet to be identified. MATERIALS & METHODS: Here we investigate the utility of a nondenatured, noncrosslinked, commercially available natural biomaterial (TissueMend(®) [TEI Biosciences, Boston, MA, USA]) for delivery of human mesenchymal stem cells (MSCs) to the murine heart. RESULTS: We found that MSCs attached, proliferated and migrated within and out of the TissueMend matrix in vitro. Human MSCs delivered to damaged murine myocardium via the matrix (2.3 × 10(4) ± 0.8 × 10(4) CD73(+) cells/matrix) were maintained in vivo for 3 weeks and underwent at least three population doublings during that period (21.9 × 10(4) ± 14.4 × 10(4) CD73(+) cells/matrix). In addition, collagen within the TissueMend matrix could be remodeled by MSCs in vivo, resulting in a significant decrease in the coefficient of alignment of fibers (0.12 ± 0.12) compared with the matrix alone (0.28 ± 0.07), and the MSCs were capable of migrating out of the matrix and into the host tissue. CONCLUSION: Thus, TissueMend matrix offers a commercially available, biocompatible and malleable vehicle for the delivery and retention of stem cells to the heart.
Authors: Dongming Hou; Eyas Al-Shaykh Youssef; Todd J Brinton; Ping Zhang; Pamela Rogers; Erik T Price; Alan C Yeung; Brian H Johnstone; Paul G Yock; Keith L March Journal: Circulation Date: 2005-08-30 Impact factor: 29.690
Authors: Paul V Kochupura; Evren U Azeloglu; Damon J Kelly; Sergey V Doronin; Stephen F Badylak; Irvin B Krukenkamp; Ira S Cohen; Glenn R Gaudette Journal: Circulation Date: 2005-08-30 Impact factor: 29.690
Authors: L Pandolfi; N Toledano Furman; Xin Wang; C Lupo; J O Martinez; M Mohamed; F Taraballi; E Tasciotti Journal: J Mater Sci Mater Med Date: 2017-02-02 Impact factor: 3.896
Authors: Jangwook P Jung; Jayne M Squirrell; Gary E Lyons; Kevin W Eliceiri; Brenda M Ogle Journal: Trends Biotechnol Date: 2011-12-31 Impact factor: 19.536
Authors: Terra N Thimm; Jayne M Squirrell; Yuming Liu; Kevin W Eliceiri; Brenda M Ogle Journal: Tissue Eng Part C Methods Date: 2015-06-17 Impact factor: 3.056
Authors: Kevin P Hanson; Jangwook P Jung; Quyen A Tran; Shao-Pu P Hsu; Rioko Iida; Visar Ajeti; Paul J Campagnola; Kevin W Eliceiri; Jayne M Squirrell; Gary E Lyons; Brenda M Ogle Journal: Tissue Eng Part A Date: 2013-02-14 Impact factor: 3.845
Authors: J Y Wang; Akf Liou; Z H Ren; L Zhang; B N Brown; X T Cui; S F Badylak; Y N Cai; Y Q Guan; Rehana K Leak; J Chen; X Ji; L Chen Journal: CNS Neurol Disord Drug Targets Date: 2013-05-01 Impact factor: 4.388
Authors: Hung-Li Tsai; Wen-Ta Chiu; Chia-Lang Fang; Shiaw-Min Hwang; Perry F Renshaw; Wen-Fu Thomas Lai Journal: Tissue Eng Part A Date: 2014-07 Impact factor: 3.845
Authors: Nicholas A Kouris; Jeremy A Schaefer; Masato Hatta; Brian T Freeman; Timothy J Kamp; Yoshihiro Kawaoka; Brenda M Ogle Journal: Stem Cells Int Date: 2012-05-30 Impact factor: 5.443